Summary

Global B2B Mold Inhibitors market size in terms of revenue is projected to reach 239.83 million USD by 2031 from 156.93 million USD in 2024, with a CAGR 5.20% during 2025-2031. Global B2B Mold Inhibitors market size in terms of sales is projected to reach 11,820 Tons by 2031 from 7,753 Tons in 2024, with a CAGR 5.84% during 2025-2031.
North America market for B2B Mold Inhibitors is estimated to increase from 44.28 million USD in 2024 to reach 58.65 million USD by 2031, at a CAGR of 4.04% during the forecast period of 2025 through 2031.
Europe market for B2B Mold Inhibitors is estimated to increase from 40.03 million USD in 2024 to reach 56.97 million USD by 2031, at a CAGR of 3.57% during the forecast period of 2025 through 2031.
Asia-Pacific market for B2B Mold Inhibitors is estimated to increase from 60.38 million USD in 2024 to reach 106.56 million USD by 2031, at a CAGR of 7.11% during the forecast period of 2025 through 2031.

The major global manufacturers of B2B Mold Inhibitors include Sanitized, Guangdong Dimei Biological Technology, Sinanen Zeomic, 3D Bio-chem, Thermaset, iHeir, Daiko Technical, Colloids, I'm Biotechnology, Guangzhou Good Nice Anti-Mold, etc. In 2024, the world's top five vendors accounted for approximately 48.32% of the revenue.
This report aims to provide a comprehensive presentation of the global market for B2B Mold Inhibitors, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding B2B Mold Inhibitors.

The B2B Mold Inhibitors market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global B2B Mold Inhibitors market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the B2B Mold Inhibitors manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation
By Company
Sanitized
Guangdong Dimei Biological Technology
Sinanen Zeomic
3D Bio-chem
Thermaset
iHeir
Daiko Technical
Colloids
I'm Biotechnology
Guangzhou Good Nice Anti-Mold
Suzhou Anmei Material Technology

Segment by Type
Powder
Coating
Masterbatch

Segment by Application
Plastics and Polymers
Textile
Building Material and Exterior Wall
Housing Equipment
Others

Production by Region
North America
Europe
China
Japan

Consumption by Region
North America
U.S.
Canada

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Europe
Germany
France
U.K.
Italy
Russia
Rest of Europe

Latin America, Middle East & Africa
Mexico
Brazil
GCC Countries

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of B2B Mold Inhibitors manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of B2B Mold Inhibitors by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of B2B Mold Inhibitors in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.

ページTOPに戻る

Table of Contents

1 B2B Mold Inhibitors Market Overview 1
1.1 Product Definition 1
1.2 B2B Mold Inhibitors by Type 1
1.2.1 Global B2B Mold Inhibitors Market Value Growth Rate Analysis by Type: 2024 VS 2031 2
1.2.2 Powder 3
1.2.3 Coating 4
1.2.4 Masterbatch 4
1.3 B2B Mold Inhibitors by Application 5
1.3.1 Global B2B Mold Inhibitors Market Value Growth Rate Analysis by Application: 2024 VS 2031 5
1.3.2 Plastics and Polymers 7
1.3.3 Textile 7
1.3.4 Building Materials and Exterior Wall 8
1.3.5 Housing Equipment 9
1.3.6 Others 10
1.4 Global Market Growth Prospects 11
1.4.1 Global B2B Mold Inhibitors Production Value Estimates and Forecasts (2020-2031) 11
1.4.2 Global B2B Mold Inhibitors Production Capacity Estimates and Forecasts (2020-2031) 12
1.4.3 Global B2B Mold Inhibitors Production Estimates and Forecasts (2020-2031) 13
1.4.4 Global B2B Mold Inhibitors Market Average Price Estimates and Forecasts (2020-2031) 14
1.5 Assumptions and Limitations 14
2 Market Competition by Manufacturers 17
2.1 Global B2B Mold Inhibitors Production Market Share by Manufacturers (2020-2025) 17
2.2 Global B2B Mold Inhibitors Production Value Market Share by Manufacturers (2020-2025) 19
2.3 Global Key Players of B2B Mold Inhibitors, Industry Ranking, 2023 VS 2024 21
2.4 Global B2B Mold Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 22
2.5 Global B2B Mold Inhibitors Average Price by Manufacturers (2020-2025) 23
2.6 Global Key Manufacturers of B2B Mold Inhibitors, Manufacturing Base Distribution and Headquarters 24
2.7 Global Key Manufacturers of B2B Mold Inhibitors, Product Offered and Application 24
2.8 Global Key Manufacturers of B2B Mold Inhibitors, Founding date 25
2.9 B2B Mold Inhibitors Market Competitive Situation and Trends 26
2.9.1 B2B Mold Inhibitors Market Concentration Rate 26
2.9.2 Global 5 and 10 Largest B2B Mold Inhibitors Players Market Share by Revenue 27
3 B2B Mold Inhibitors Production by Region 28
3.1 Global B2B Mold Inhibitors Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031 28
3.2 Global B2B Mold Inhibitors Production Value by Region (2020-2031) 30
3.2.1 Global B2B Mold Inhibitors Production Value Market Share by Region (2020-2025) 30
3.2.2 Global Forecasted Production Value of B2B Mold Inhibitors by Region (2026-2031) 30
3.3 Global B2B Mold Inhibitors Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031 31
3.4 Global B2B Mold Inhibitors Production by Region (2020-2031) 33
3.4.1 Global B2B Mold Inhibitors Production Market Share by Region (2020-2025) 33
3.4.2 Global Forecasted Production of B2B Mold Inhibitors by Region (2026-2031) 33
3.5 Global B2B Mold Inhibitors Market Price Analysis by Region (2020-2025) 34
3.6 Global B2B Mold Inhibitors Production and Value, Year-over-Year Growth 35
3.6.1 North America B2B Mold Inhibitors Production Value Estimates and Forecasts (2020-2031) 35
3.6.2 Europe B2B Mold Inhibitors Production Value Estimates and Forecasts (2020-2031) 36
3.6.3 China B2B Mold Inhibitors Production Value Estimates and Forecasts (2020-2031) 37
3.6.4 Japan B2B Mold Inhibitors Production Value Estimates and Forecasts (2020-2031) 38
4 B2B Mold Inhibitors Consumption by Region 39
4.1 Global B2B Mold Inhibitors Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031 39
4.2 Global B2B Mold Inhibitors Consumption by Region (2020-2031) 41
4.2.1 Global B2B Mold Inhibitors Consumption by Region (2020-2031) 41
4.2.2 Global B2B Mold Inhibitors Forecasted Consumption by Region (2026-2031) 41
4.3 North America 42
4.3.1 North America B2B Mold Inhibitors Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 43
4.3.2 North America B2B Mold Inhibitors Consumption by Country (2020-2031) 43
4.3.3 U.S. 44
4.3.4 Canada 45
4.4 Europe 45
4.4.1 Europe B2B Mold Inhibitors Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 46
4.4.2 Europe B2B Mold Inhibitors Consumption by Country (2020-2031) 46
4.4.3 Germany 48
4.4.4 France 48
4.4.5 U.K. 49
4.4.6 Italy 49
4.4.7 Russia 50
4.5 Asia Pacific 51
4.5.1 Asia Pacific B2B Mold Inhibitors Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 51
4.5.2 Asia Pacific B2B Mold Inhibitors Consumption by Region (2020-2031) 52
4.5.3 China 53
4.5.4 Japan 54
4.5.5 South Korea 54
4.5.6 Southeast Asia 55
4.5.7 India 56
4.5.8 Australia 56
4.6 Latin America 57
4.6.1 Latin America B2B Mold Inhibitors Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 57
4.6.2 Latin America B2B Mold Inhibitors Consumption by Country (2020-2031) 58
4.6.3 Mexico 59
4.6.4 Brazil 59
4.7 Middle East and Africa 60
4.7.1 Middle East and Africa B2B Mold Inhibitors Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 60
4.7.2 Middle East and Africa B2B Mold Inhibitors Consumption by Country (2020-2031) 61
4.7.3 Saudi Arabia 62
4.7.4 UAE 63
4.7.5 Egypt 63
4.7.6 South Africa 64
5 Segment by Type 65
5.1 Global B2B Mold Inhibitors Production by Type (2020-2031) 65
5.1.1 Global B2B Mold Inhibitors Production by Type (2020-2025) 65
5.1.2 Global B2B Mold Inhibitors Production by Type (2026-2031) 65
5.1.3 Global B2B Mold Inhibitors Production Market Share by Type (2020-2031) 65
5.2 Global B2B Mold Inhibitors Production Value by Type (2020-2031) 66
5.2.1 Global B2B Mold Inhibitors Production Value by Type (2020-2025) 66
5.2.2 Global B2B Mold Inhibitors Production Value by Type (2026-2031) 67
5.2.3 Global B2B Mold Inhibitors Production Value Market Share by Type (2020-2031) 67
5.3 Global B2B Mold Inhibitors Price by Type (2020-2031) 68
6 Segment by Application 70
6.1 Global B2B Mold Inhibitors Production by Application (2020-2031) 70
6.1.1 Global B2B Mold Inhibitors Production by Application (2020-2025) 70
6.1.2 Global B2B Mold Inhibitors Production by Application (2026-2031) 70
6.1.3 Global B2B Mold Inhibitors Production Market Share by Application (2020-2031) 71
6.2 Global B2B Mold Inhibitors Production Value by Application (2020-2031) 72
6.2.1 Global B2B Mold Inhibitors Production Value by Application (2020-2025) 72
6.2.2 Global B2B Mold Inhibitors Production Value by Application (2026-2031) 73
6.2.3 Global B2B Mold Inhibitors Production Value Market Share by Application (2020-2031) 73
6.3 Global B2B Mold Inhibitors Price by Application (2020-2031) 74
7 Key Companies Profiled 76
7.1 Sanitized 76
7.1.1 Sanitized B2B Mold Inhibitors Company Information 76
7.1.2 Sanitized B2B Mold Inhibitors Product Portfolio 76
7.1.3 Sanitized B2B Mold Inhibitors Production, Value, Price and Gross Margin (2020-2025) 77
7.1.4 Sanitized Main Business and Markets Served 77
7.1.5 Sanitized Recent Developments/Updates 78
7.2 Guangdong Dimei Biological Technology 79
7.2.1 Guangdong Dimei Biological Technology B2B Mold Inhibitors Company Information 79
7.2.2 Guangdong Dimei Biological Technology B2B Mold Inhibitors Product Portfolio 79
7.2.3 Guangdong Dimei Biological Technology B2B Mold Inhibitors Production, Value, Price and Gross Margin (2020-2025) 80
7.2.4 Guangdong Dimei Biological Technology Main Business and Markets Served 81
7.3 Sinanen Zeomic 81
7.3.1 Sinanen Zeomic B2B Mold Inhibitors Company Information 81
7.3.2 Sinanen Zeomic B2B Mold Inhibitors Product Portfolio 82
7.3.3 Sinanen Zeomic B2B Mold Inhibitors Production, Value, Price and Gross Margin (2020-2025) 82
7.3.4 Sinanen Zeomic Main Business and Markets Served 83
7.3.5 Sinanen Zeomic Recent Developments/Updates 83
7.4 3D Bio-chem 83
7.4.1 3D Bio-chem B2B Mold Inhibitors Company Information 84
7.4.2 3D Bio-chem B2B Mold Inhibitors Product Portfolio 84
7.4.3 3D Bio-chem B2B Mold Inhibitors Production, Value, Price and Gross Margin (2020-2025) 86
7.4.4 3D Bio-chem Main Business and Markets Served 87
7.5 Thermaset 88
7.5.1 Thermaset B2B Mold Inhibitors Company Information 88
7.5.2 Thermaset B2B Mold Inhibitors Product Portfolio 88
7.5.3 Thermaset B2B Mold Inhibitors Production, Value, Price and Gross Margin (2020-2025) 90
7.5.4 Thermaset Main Business and Markets Served 90
7.6 iHeir 91
7.6.1 iHeir B2B Mold Inhibitors Company Information 91
7.6.2 iHeir B2B Mold Inhibitors Product Portfolio 91
7.6.3 iHeir B2B Mold Inhibitors Production, Value, Price and Gross Margin (2020-2025) 95
7.6.4 iHeir Main Business and Markets Served 95
7.7 Daiko Technical 96
7.7.1 Daiko Technical B2B Mold Inhibitors Company Information 96
7.7.2 Daiko Technical B2B Mold Inhibitors Product Portfolio 96
7.7.3 Daiko Technical B2B Mold Inhibitors Production, Value, Price and Gross Margin (2020-2025) 97
7.7.4 Daiko Technical Main Business and Markets Served 98
7.8 Colloids 98
7.8.1 Colloids B2B Mold Inhibitors Company Information 98
7.8.2 Colloids B2B Mold Inhibitors Product Portfolio 99
7.8.3 Colloids B2B Mold Inhibitors Production, Value, Price and Gross Margin (2020-2025) 101
7.8.4 Colloids Main Business and Markets Served 101
7.9 I'm Biotechnology 101
7.9.1 I'm Biotechnology B2B Mold Inhibitors Company Information 102
7.9.2 I'm Biotechnology B2B Mold Inhibitors Product Portfolio 102
7.9.3 I'm Biotechnology B2B Mold Inhibitors Production, Value, Price and Gross Margin (2020-2025) 108
7.9.4 I'm Biotechnology Main Business and Markets Served 108
7.10 Guangzhou Good Nice Anti-Mold 108
7.10.1 Guangzhou Good Nice Anti-Mold B2B Mold Inhibitors Company Information 109
7.10.2 Guangzhou Good Nice Anti-Mold B2B Mold Inhibitors Product Portfolio 109
7.10.3 Guangzhou Good Nice Anti-Mold B2B Mold Inhibitors Production, Value, Price and Gross Margin (2020-2025) 113
7.10.4 Guangzhou Good Nice Anti-Mold Main Business and Markets Served 113
7.11 Suzhou Anmei Material Technology 114
7.11.1 Suzhou Anmei Material Technology B2B Mold Inhibitors Company Information 114
7.11.2 Suzhou Anmei Material Technology B2B Mold Inhibitors Product Portfolio 115
7.11.3 Suzhou Anmei Material Technology B2B Mold Inhibitors Production, Value, Price and Gross Margin (2020-2025) 116
7.11.4 Suzhou Anmei Material Technology Main Business and Markets Served 116
8 Industry Chain and Sales Channels Analysis 117
8.1 B2B Mold Inhibitors Industry Chain Analysis 117
8.2 B2B Mold Inhibitors Raw Material Supply Analysis 117
8.2.1 Key Raw Materials 117
8.2.2 Raw Materials Key Suppliers 118
8.3 B2B Mold Inhibitors Production Mode & Process Analysis 119
8.4 B2B Mold Inhibitors Sales and Marketing 120
8.4.1 B2B Mold Inhibitors Sales Channels 120
8.4.2 B2B Mold Inhibitors Distributors 120
8.5 B2B Mold Inhibitors Customer Analysis 121
9 B2B Mold Inhibitors Market Dynamics 122
9.1 B2B Mold Inhibitors Industry Trends 122
9.2 B2B Mold Inhibitors Market Drivers 123
9.3 B2B Mold Inhibitors Market Challenges 124
9.4 B2B Mold Inhibitors Market Restraints 125
10 Research Findings and Conclusion 126
11 Methodology and Data Source 128
11.1 Methodology/Research Approach 128
11.1.1 Research Programs/Design 128
11.1.2 Market Size Estimation 129
11.1.3 Market Breakdown and Data Triangulation 130
11.2 Data Source 131
11.2.1 Secondary Sources 131
11.2.2 Primary Sources 132
11.3 Author List 133
11.4 Disclaimer 134